Nicolau, J. C. (2019). Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: A prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial.
Citación estilo ChicagoNicolau, José Carlos. Effects of Alirocumab On Cardiovascular and Metabolic Outcomes After Acute Coronary Syndrome in Patients With or Without Diabetes: A Prespecified Analysis of the ODYSSEY OUTCOMES Randomised Controlled Trial. 2019.
Cita MLANicolau, José Carlos. Effects of Alirocumab On Cardiovascular and Metabolic Outcomes After Acute Coronary Syndrome in Patients With or Without Diabetes: A Prespecified Analysis of the ODYSSEY OUTCOMES Randomised Controlled Trial. 2019.
Precaución: Estas citas no son 100% exactas.